Who Owns Regeneron Pharmaceuticals Stock?
NASDAQ: REGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 93.57%
- Held by insiders
- 2.08%
- Institutional holders
- 1,915
- Institutions 93.6%
- Insiders 2.1%
- Public and other 4.3%
Who owns Regeneron Pharmaceuticals stock?
Institutional investors own about 93.6% of Regeneron Pharmaceuticals's shares, spread across 1,915 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.08% of REGN.
The largest institutional holders are Blackrock Inc. (9.01%), Vanguard Capital Management LLC (6.56%) and Dodge & Cox Inc. (4.82%). Together, the top 10 institutions control 43.3% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their REGN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of REGN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 9.11M | 9.01% | +1.9% |
| Vanguard Capital Management LLC | 6.63M | 6.56% | -0.4% |
| Dodge & Cox Inc. | 4.87M | 4.82% | +9.3% |
| State Street Corporation | 4.83M | 4.78% | +3.6% |
| Invesco Ltd. | 3.94M | 3.90% | +0.9% |
| JPMORGAN CHASE & CO | 3.77M | 3.73% | -12.5% |
| Vanguard Portfolio Management LLC | 3.18M | 3.14% | +84.5% |
| Franklin Resources, Inc. | 2.77M | 2.74% | +1.8% |
| Geode Capital Management, LLC | 2.63M | 2.60% | +0.7% |
| Nuveen, LLC | 2.02M | 2.00% | -2.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of REGN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.27M | 3.23% |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 3.12M | 3.09% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59M | 2.56% |
| Invesco QQQ Trust, Series 1 | 2.22M | 2.19% |
| iShares Trust-iShares Core S&P 500 ETF | 1.33M | 1.32% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30M | 1.28% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.22M | 1.21% |
| PUTNAM LARGE CAP VALUE FUND | 1.15M | 1.14% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 1.12M | 1.10% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.07M | 1.06% |
Frequently asked questions
Who is the largest shareholder of Regeneron Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of REGN, owning 9.01% of shares outstanding (9.11M shares) as of its latest 13F filing.
What percentage of Regeneron Pharmaceuticals is owned by institutions?
Institutions own about 93.6% of REGN shares and 95.6% of the public float.
How much of Regeneron Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 2.08% of REGN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.